GO:0043014 alpha-tubulin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043014 alpha-tubulin binding is a molecular function defined as binding to the microtubule constituent protein alpha-tubulin.
• Alpha-tubulin binding underlies microtubule polymerization, kinetochore-microtubule attachment, and mitotic spindle function.
• Tubulin cofactors and modifying enzymes regulate alpha-tubulin biogenesis, detyrosination, glutamylation, acetylation, and methylation.
• Small molecules and natural products can bind alpha-tubulin or adjacent sites, making this function a drug-target hotspot.
• Dysregulation of alpha-tubulin binding is linked to cancer, neurodegeneration, and parasitic infections.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are key tools for dissecting alpha-tubulin binding mechanisms.
Description
Alpha-tubulin binding (GO:0043014) is a molecular function that describes the physical interaction between a protein or molecule and alpha-tubulin, the building block of microtubules. Microtubules are dynamic polymers essential for cell division, intracellular transport, and cytoskeletal organization, and their proper assembly depends on proteins that bind alpha-tubulin directly. This GO term captures a wide range of interactions, from structural components of the tubulin folding pathway to enzymes that modify alpha-tubulin post-translationally. Researchers study alpha-tubulin binding to understand how microtubule dynamics are controlled and how perturbations contribute to disease. For example, detyrosination of alpha-tubulin fine-tunes kinetochore-microtubule attachments during mitosis, while demethylation of alpha-tubulin by KDM4A regulates microtubule polymerization and cell division. Small molecules such as podophyllotoxin derivatives and oryzalin bind alpha-tubulin or adjacent sites, highlighting the pharmacological relevance of this function. Because alpha-tubulin binding is central to both normal physiology and disease, it is a frequent target for functional genomics and drug discovery.
alpha-tubulin binding At A Glance
| GO ID | GO:0043014 |
|---|---|
| GO term | alpha-tubulin binding |
| Ontology | molecular_function |
| Synonym | alpha tubulin binding |
| Definition | Binding to the microtubule constituent protein alpha-tubulin. |
| Major function | Mediates interactions with alpha-tubulin for microtubule assembly, modification, and regulation. |
| Related processes | Microtubule polymerization, kinetochore attachment, mitosis, tubulin biogenesis. |
| Example regulators | Tubulin cofactors, KDM4A, NQO1, detyrosination enzymes. |
| Disease relevance | Cancer, neurodegeneration, parasitic infections. |
What Is GO:0043014?
According to the Gene Ontology, GO:0043014 alpha-tubulin binding is the molecular function of binding to the microtubule constituent protein alpha-tubulin. In other words, it is any selective and non-covalent interaction with alpha-tubulin, whether alpha-tubulin is free, in a heterodimer with beta-tubulin, or incorporated into a microtubule polymer.
Why Is alpha-tubulin binding Important in Cell Biology?
Alpha-tubulin binding is important because it governs the assembly, stability, and modification of microtubules, which are essential for cell division, shape, and intracellular transport. Proteins that bind alpha-tubulin control when and where microtubules polymerize, how they attach to kinetochores, and how they are modified to fine-tune their functions. Disrupting these interactions can lead to mitotic defects, altered cell proliferation, and disease. Moreover, many natural products and synthetic compounds target alpha-tubulin binding sites, making this function a validated node for drug discovery.
• Regulates microtubule polymerization and dynamics, which are fundamental to cell division and motility.
• Controls kinetochore-microtubule attachments and chromosome segregation fidelity during mitosis.
• Enables post-translational modifications of alpha-tubulin, such as detyrosination, glutamylation, acetylation, and methylation.
• Supports tubulin biogenesis and degradation through tubulin cofactors.
• Provides a binding site for small-molecule inhibitors like podophyllotoxin derivatives and oryzalin.
• Is implicated in cancer when mitotic regulation is disrupted.
• Contributes to neurodegeneration when microtubule stability is compromised.
• Offers targets for antiparasitic drugs in organisms like Toxoplasma gondii.
• Serves as a model for studying protein-protein and protein-ligand interactions at the cytoskeleton.
• Is a focus for CRISPR-based functional studies of tubulin regulators.
Molecular Mechanism of alpha-tubulin binding
Alpha-tubulin recognition and binding interface
In simple terms: Proteins that bind alpha-tubulin recognize specific shapes and chemical marks on its surface.
Alpha-tubulin binding typically involves recognition of specific structural features on alpha-tubulin, including its GTP-binding pocket and surface loops that vary with post-translational modifications. Structural studies of glutamylation have revealed how enzymes distinguish alpha-tubulin from beta-tubulin and how modification state affects binding. Similarly, a novel alpha-tubulin binding site model for oryzalin resistance in Toxoplasma gondii highlights species-specific differences in the binding interface.
Tubulin cofactors in biogenesis and degradation
In simple terms: Helper proteins called tubulin cofactors assist alpha-tubulin folding, assembly, and turnover.
Tubulin cofactors (TBCs) bind alpha- and beta-tubulin to catalyze their biogenesis and degradation. A unified mechanism has been proposed in which these cofactors use conserved domains to recognize and process tubulin subunits, ensuring proper heterodimer formation. This function is essential for maintaining the pool of assembly-competent alpha-tubulin.
Post-translational modifications and binding
In simple terms: Chemical tags on alpha-tubulin change how other proteins bind to it.
Detyrosination of alpha-tubulin fine-tunes kinetochore-microtubule attachments, affecting the recruitment of binding partners at the kinetochore. Glutamylation is a modification that alters the interaction of alpha-tubulin with microtubule-associated proteins and motors, and its structural basis has been resolved. KDM4A acts as an alpha-tubulin demethylase, and its binding to alpha-tubulin regulates microtubule polymerization and mitosis. NQO1 undergoes a redox-mediated conformational change that controls its binding to microtubules and alpha-tubulin acetylation.
Small-molecule and drug interactions
In simple terms: Some drugs and natural compounds work by binding to alpha-tubulin or nearby sites.
Podophyllotoxin derivatives form complexes with tubulin and reveal a potential binding site in alpha-tubulin adjacent to the colchicine site, providing a structural basis for tubulin polymerization inhibition. Oryzalin resistance in Toxoplasma gondii is linked to a novel alpha-tubulin binding site model, demonstrating that species-specific differences can be exploited for antiparasitic drug design.
Regulation by redox and signaling
In simple terms: Cellular signals and redox state can change how proteins bind alpha-tubulin.
The redox state of NQO1 controls a conformational change that modulates its binding to microtubules and its role in alpha-tubulin acetylation. This illustrates how alpha-tubulin binding is not static but can be regulated by cellular redox and signaling pathways.
Key Genes Involved in GO:0043014 alpha-tubulin binding
The following genes and proteins are directly implicated in alpha-tubulin binding or its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TUBA1A | Alpha-tubulin isoform; primary binding partner | Core component of microtubules; mutations linked to neurodevelopmental disorders. |
| TBCA | Tubulin cofactor A; binds alpha-tubulin | Assists in alpha-tubulin folding and biogenesis. |
| TBCB | Tubulin cofactor B; binds alpha-tubulin | Involved in tubulin heterodimer formation and degradation. |
| TBCC | Tubulin cofactor C; binds alpha-tubulin | Catalyzes GTP hydrolysis during tubulin folding. |
| TBCD | Tubulin cofactor D; binds alpha-tubulin | Participates in tubulin biogenesis and microtubule dynamics. |
| TBCE | Tubulin cofactor E; binds alpha-tubulin | Essential for alpha-tubulin maturation. |
| KDM4A | Alpha-tubulin demethylase | Regulates microtubule polymerization and mitosis. |
| NQO1 | Redox-dependent alpha-tubulin binding protein | Controls microtubule binding and alpha-tubulin acetylation. |
| VASH1 | Tubulin detyrosination enzyme | Fine-tunes kinetochore-microtubule attachments. |
| VASH2 | Tubulin detyrosination enzyme | Regulates mitotic spindle function. |
| TTLL1 | Tubulin glutamylase | Adds glutamate to alpha-tubulin, affecting binding. |
| TTLL4 | Tubulin glutamylase | Modifies alpha-tubulin and influences microtubule interactions. |
| TTLL6 | Tubulin glutamylase | Regulates microtubule stability via glutamylation. |
| TTLL7 | Tubulin glutamylase | Modifies alpha-tubulin in neurons. |
| CCP1 | Tubulin deglutamylase | Removes glutamate from alpha-tubulin, reversing modifications. |
| CCP5 | Tubulin deglutamylase | Regulates glutamylation state of alpha-tubulin. |
| MAP1B | Microtubule-associated protein | Binds alpha-tubulin and regulates microtubule dynamics. |
| MAP2 | Microtubule-associated protein | Binds alpha-tubulin in neurons. |
How Is alpha-tubulin binding Regulated?
Alpha-tubulin binding is regulated at multiple levels. Post-translational modifications such as detyrosination, glutamylation, acetylation, and methylation alter the affinity of binding partners for alpha-tubulin. For example, detyrosination fine-tunes kinetochore-microtubule attachments, while glutamylation changes the interaction surface of alpha-tubulin. KDM4A-mediated demethylation of alpha-tubulin regulates microtubule polymerization and mitosis. Redox signaling through NQO1 controls a conformational change that modulates binding to microtubules and alpha-tubulin acetylation. Tubulin cofactors also regulate the availability of assembly-competent alpha-tubulin by controlling its biogenesis and degradation.
alpha-tubulin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KDM4A | Cancer; mitotic regulation | Knockout and overexpression in cancer cell lines. |
| NQO1 | Redox-related diseases; microtubule acetylation | Point mutation of redox-sensitive residues. |
| TUBA1A | Neurodevelopmental disorders | Knock-in of patient mutations in neurons. |
| VASH1/VASH2 | Cancer; mitotic defects | Knockout in HeLa or RPE1 cells. |
| TBCD | Tubulin biogenesis disorders | Knockout in cell models to study tubulin folding. |
Cancer and mitotic dysregulation
Alpha-tubulin binding proteins are critical for mitotic spindle assembly and chromosome segregation. Detyrosination of alpha-tubulin fine-tunes kinetochore-microtubule attachments, and errors in this process can lead to aneuploidy and cancer. KDM4A, an alpha-tubulin demethylase, regulates microtubule polymerization and cell mitosis, and its dysregulation has been linked to tumorigenesis. Small molecules that bind alpha-tubulin, such as podophyllotoxin derivatives, are investigated as anticancer agents because they inhibit tubulin polymerization.
Neurodegeneration and microtubule stability
Proper alpha-tubulin binding is essential for neuronal microtubule stability and transport. Disruption of tubulin modifications and binding partners has been implicated in neurodegenerative conditions. The game of tubulins review highlights how tubulin diversity and modifications contribute to neuronal function and disease.
Parasitic infections
Alpha-tubulin binding sites are targets for antiparasitic drugs. In Toxoplasma gondii, a novel alpha-tubulin binding site model explains resistance to oryzalin, a herbicide that disrupts microtubules. This suggests that species-specific differences in alpha-tubulin binding can be exploited for selective drug development.
From alpha-tubulin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KDM4A affect microtubule polymerization? | KDM4A knockout cell line. |
| How does NQO1 redox state regulate alpha-tubulin binding? | Point-mutation knock-in of NQO1 redox residues. |
| What is the role of alpha-tubulin detyrosination in mitosis? | VASH1/VASH2 knockout or overexpression. |
| How do tubulin cofactors contribute to alpha-tubulin biogenesis? | Knockout of TBCA-TBCE in cultured cells. |
| Can a specific alpha-tubulin mutation confer drug resistance? | Knock-in of oryzalin-resistance mutations in Toxoplasma. |
| Does alpha-tubulin acetylation affect binding partners? | Tagged knock-in of acetyl-mimetic or non-acetylatable alpha-tubulin. |
How to Study the alpha-tubulin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-sedimentation assay | Binding of proteins to polymerized microtubules | In vitro alpha-tubulin binding studies. |
| Surface plasmon resonance | Kinetics and affinity of alpha-tubulin interactions | Quantifying binding constants. |
| Cryo-EM | High-resolution structure of tubulin complexes | Visualizing drug binding sites. |
| Live-cell imaging | Microtubule dynamics and kinetochore attachment | Mitosis studies. |
| Mass spectrometry | Post-translational modifications on alpha-tubulin | Mapping glutamylation and acetylation. |
| CRISPR knockout screening | Genes required for alpha-tubulin binding functions | Identifying novel regulators. |
| Immunofluorescence | Localization of modified alpha-tubulin | Detecting detyrosination or acetylation. |
| Western blotting | Expression and modification levels | Validating knockout or overexpression. |
Structural biology and binding assays
X-ray crystallography and cryo-EM have been used to resolve the structural basis for alpha-tubulin-specific glutamylation and drug binding. In vitro binding assays such as co-sedimentation and surface plasmon resonance can measure affinity between alpha-tubulin and candidate proteins.
Live-cell imaging and dynamics
Fluorescence microscopy of tagged alpha-tubulin and binding partners allows real-time visualization of microtubule dynamics and kinetochore attachments. Photo-conversion and FRAP can quantify binding turnover at microtubule plus ends.
Proteomics and modification analysis
Mass spectrometry-based proteomics can identify post-translational modifications on alpha-tubulin and their effect on interactomes. Antibodies specific to detyrosinated, glutamylated, or acetylated alpha-tubulin are used in Western blotting and immunofluorescence.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for alpha-tubulin binding-dependent processes such as mitosis. Follow-up validation with focused libraries enables mechanistic studies.
How CRISPR Can Be Used to Study GO:0043014 alpha-tubulin binding
Knockout
CRISPR knockout of genes encoding alpha-tubulin binding proteins, such as KDM4A or tubulin cofactors, can reveal their essential roles in microtubule polymerization and mitosis. Knockout cell lines are used to assess changes in microtubule dynamics, cell cycle progression, and drug sensitivity.
Point Mutation
Point mutations can be introduced into alpha-tubulin or its binding partners to dissect specific interaction interfaces. For example, mutating the redox-sensitive residues of NQO1 can test how conformational changes affect alpha-tubulin binding and acetylation. Similarly, mutations in the alpha-tubulin binding site can confer or reverse drug resistance.
Knock-in
Knock-in of tagged or mutant alpha-tubulin allows tracking of its localization and modification state in live cells. Knock-in of disease-associated mutations in TUBA1A can model neurodevelopmental defects.
Overexpression
Overexpression of alpha-tubulin binding proteins such as KDM4A or VASH1 can drive excessive microtubule modification and mitotic defects, providing gain-of-function models. Overexpression of tubulin cofactors can also perturb the balance of tubulin biogenesis.
How EDITGENE Supports alpha-tubulin binding Research
Researchers studying alpha-tubulin binding-related genes often need to determine whether a candidate gene is causally involved in microtubule regulation, mitosis, or disease. EDITGENE provides CRISPR-based cell model services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for alpha-tubulin binding research.
Frequently Asked Questions About alpha-tubulin binding
What is alpha-tubulin binding?
Alpha-tubulin binding (GO:0043014) is the molecular function of binding to alpha-tubulin, a core component of microtubules.
What genes are involved in alpha-tubulin binding?
Genes include TUBA1A, tubulin cofactors (TBCA-TBCE), KDM4A, NQO1, VASH1/2, and TTLL family members.
How is alpha-tubulin binding regulated?
It is regulated by post-translational modifications such as detyrosination, glutamylation, acetylation, and methylation, as well as redox signaling.
Why is alpha-tubulin binding important in cancer?
It controls mitotic spindle assembly and chromosome segregation; dysregulation can lead to aneuploidy and cancer.
What methods are used to study alpha-tubulin binding?
Common methods include co-sedimentation, surface plasmon resonance, cryo-EM, live-cell imaging, mass spectrometry, and CRISPR screens.
Can CRISPR be used to study alpha-tubulin binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect alpha-tubulin binding mechanisms.
What diseases are linked to alpha-tubulin binding?
Cancer, neurodegeneration, and parasitic infections are linked to defects in alpha-tubulin binding and microtubule regulation.
What is the role of tubulin cofactors in alpha-tubulin binding?
Tubulin cofactors bind alpha-tubulin to assist in its folding, heterodimer formation, and degradation.
How does KDM4A affect alpha-tubulin?
KDM4A acts as an alpha-tubulin demethylase, regulating microtubule polymerization and cell mitosis.
What is the clinical relevance of alpha-tubulin binding sites?
They are targets for anticancer and antiparasitic drugs, such as podophyllotoxin derivatives and oryzalin.
Conclusion
Alpha-tubulin binding (GO:0043014) is a fundamental molecular function that governs microtubule dynamics, mitosis, and cellular architecture. Its regulation by post-translational modifications, redox signaling, and tubulin cofactors makes it a rich area for mechanistic studies. Dysregulation of alpha-tubulin binding is implicated in cancer, neurodegeneration, and parasitic infections, and its binding sites are validated drug targets. CRISPR-based cell models are powerful tools to dissect these mechanisms and accelerate therapeutic development.
References
- 1. Girão H et al.. 2024. α-tubulin detyrosination fine-tunes kinetochore-microtubule attachments.. Nat Commun 15(1):9720 PMID: 39521805
- 2. Mahalingan KK et al.. 2024. Structural basis for α-tubulin-specific and modification state-dependent glutamylation.. Nat Chem Biol 20(11):1493-1504 PMID: 38658656
- 3. Kristensson MA. 2021. The Game of Tubulins.. Cells 10(4) PMID: 33800665
- 4. Cao S et al.. 2025. KDM4A serves as an α-tubulin demethylase regulating microtubule polymerization and cell mitosis.. Sci Adv 11(44):eadv6637 PMID: 41171906
- 5. Zhao W et al.. 2024. Podophyllotoxin derivatives-tubulin complex reveals a potential binding site of tubulin polymerization inhibitors in α-tubulin adjacent to colchicine site.. Int J Biol Macromol 276(Pt 1):133678 PMID: 38971286
- 6. Flores-León CD et al.. 2022. Molecular basis of Toxoplasma gondii oryzalin resistance from a novel α-tubulin binding site model.. Arch Biochem Biophys 730:109398 PMID: 36116504
- 7. Siegel D et al.. 2021. A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation.. Redox Biol 39:101840 PMID: 33360352
- 8. Taheri A et al.. 2026. A unified mechanism for tubulin cofactors catalyzing α/β-tubulin biogenesis and degradation.. Sci Adv 12(19):eaee2303 PMID: 42102195
